Firms, funds, people, portfolio companies and transactions from sworn filings and cited announcements, kept as a graph with a date and a source on every edge. Reported gross assets are never fund size, regulatory AUM is never dry powder, and a deal value prints only when someone disclosed it.

The names on this page are hidden. Create a free account and they fill in. No card, and every figure, date and source on this page is public either way.

Transactions / T••••

New M••••••• Capital Partners with T••••

Platform acquisitionannouncedannounced Jul 11, 2016Fact
What happened
Target
T••••
Platform
not an add-on on record
Control
Control
Share acquired
unknown
Industry
unknown
Target location
NY, US
Seller kind
unknown
Rollover
unknown
Values, only where disclosed
Enterprise value
Not disclosed
Purchase price
Not disclosed
Equity value
Not disclosed
Target revenue
Not disclosed
Target EBITDA
Not disclosed
Multiple
Not disclosed
Parties and roles
4 named
Buy side
  • A•••• M••••Deal partnerconfirmed
    ““T•••• is the high quality leader in its space, and we are excited to partner with the T•••• team to support the next phase of growth,” said A•••• M••••, Managing Director at New M••••••• Capital.”
  • N•• M••••••• C••••••• L••Sponsorconfirmed
    “July 11, 2016 – T•••• Pharmaceuticals, Inc., a leading provider of innovative therapeutic and cosmetic skin care products, today announced that it has partnered with N•• M••••••• C••••••• L••, a growth-oriented investment firm that currently manages over $15 billion in assets.”
Side not stated
  • B••• S••••••Managementconfirmed
    ““New M••••••• is the perfect partner to help T•••• execute on its growth plans,” said B••• S••••••, President and CEO of T••••.”
  • T••••Targetconfirmed
    “New M••••••• Capital Partners with T••••”
Evidence
“New M••••••• Capital Partners with T••••”
Press release wires (PR Newswire, GlobeNewswire, Business Wire public pages and RSS)confidence 80%recorded Sep 15, 2026